INSM

NASDAQ · Biotechnology

Insmed Inc

Nasdaq 100 Large-Cap Stocks Blue Chip Stocks Biotech Stocks Healthcare Stocks

$163.52

+10.20 (+6.65%)

As of Mar 31, 9:37 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 24 92%

Hold 2 8%

Sell 0 0%

Price Target

Analyst Price Target -12.3% upside

Low Target $91.17

Average Target $143.40

High Target $177.14

Current Price $163.52

Current
$163.52

Target
$143.40

$91.17 $143.40 avg $177.14

Scenario Analysis

Bear Case

$91.17

-44.2%

Low target

Base Case

$143.40

-12.3%

Avg target

Bull Case

$177.14

+8.3%

High target

Risk/Reward

0.2x

Unfavorable

Price in Context

52-Week High

$212.75

-23.1% from high

52-Week Low

$60.40

+170.7% from low

50-Day SMA

$168.11

-2.7% vs SMA

200-Day SMA

$139.54

+17.2% vs SMA

RSI (14)

54.8

Neutral

Target vs 52W High

$143.40

-32.6% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+18.4%
AMGN Amgen Inc	Hold	42	50%	$190.87	-45.8%
GILD Gilead Sciences Inc	Strong Buy	38	79%	$362.68	+160.2%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-1.8%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.1%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-69.1%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-12.3%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-28.5%